This BRAF variant, in the past also referred to as V599E, is detectable in about 60% of human melanomas [10,11,12,13] and activates MEK as a part of the mitogen-activated protein kinase (MAPK) pathway [8]. Here, MAP2K7 is linked to melanoma.